Nuvasive Inc
NUVA
Market Cap$0
Close$
$44.54
12% upside
Current Fair Value
12% upsideUndervalued by 12% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $714.82 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.52 |
| Beta | 0.0 |
| Outstanding Shares | 52,449,167 |
| Avg 30 Day Volume | 0 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | -0.0 |
| Price to Sales | 1.73 |
| Price to Book Ratio | 2.34 |
| Enterprise Value to Revenue | 0.58 |
| Enterprise Value to EBIT | 8.66 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 1.11 |
| Debt to Equity | 0.89 |
Revenue Sources
No data
ESG Score
No data
About Nuvasive Inc
2,800 employees
CEO: J. Christopher Barry NuVasive is a medical devices company based in San Diego, California. The company primarily develops medical devices and procedures for minimally invasive spine surgery. NuVasive's products include software systems for surgical planning ...